News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
219,984 Results
Type
Article (18393)
Company Profile (161)
Press Release (201430)
Section
Business (62197)
Career Advice (198)
Deals (9079)
Drug Delivery (53)
Drug Development (34076)
Employer Resources (34)
FDA (6770)
Job Trends (6303)
News (112853)
Policy (11356)
Tag
Academia (1595)
Alliances (17812)
Alzheimer's disease (529)
Approvals (6753)
Artificial intelligence (72)
Bankruptcy (51)
Best Places to Work (5960)
Biosimilars (38)
Biotechnology (120)
Breast cancer (59)
Cancer (537)
Cardiovascular disease (52)
Career advice (178)
CAR-T (40)
Cell therapy (118)
Clinical research (27572)
Collaboration (215)
Compensation (73)
COVID-19 (1065)
C-suite (55)
Cystic fibrosis (47)
Data (652)
Diabetes (81)
Diagnostics (2147)
Drug pricing (47)
Earnings (18421)
Events (32410)
Executive appointments (160)
FDA (7038)
Funding (142)
Gene editing (48)
Gene therapy (113)
GLP-1 (328)
Government (1571)
Healthcare (7654)
Infectious disease (1106)
Inflammatory bowel disease (79)
IPO (4327)
Job creations (726)
Job search strategy (170)
Layoffs (117)
Legal (1792)
Lung cancer (85)
Manufacturing (76)
Medical device (2574)
Medtech (2575)
Mergers & acquisitions (4827)
Metabolic disorders (228)
Neuroscience (651)
NextGen Class of 2024 (2154)
Non-profit (1716)
Northern California (697)
Obesity (144)
Opinion (65)
People (21982)
Phase I (7635)
Phase II (11161)
Phase III (10772)
Pipeline (219)
Postmarket research (1434)
Preclinical (3082)
Radiopharmaceuticals (141)
Rare diseases (126)
Real estate (1545)
Regulatory (8635)
Research institute (1354)
Southern California (532)
Startups (1378)
United States (5838)
Vaccines (233)
Weight loss (94)
Date
Last 7 days (296)
Last 30 days (1472)
Last 365 days (15858)
2024 (14517)
2023 (16999)
2022 (21167)
2021 (21961)
2020 (20063)
2019 (17313)
2018 (12967)
2017 (12133)
2016 (11310)
2015 (12197)
2014 (8539)
2013 (7001)
2012 (7095)
2011 (7066)
2010 (5729)
Location
Africa (233)
Asia (14877)
Australia (2079)
California (1446)
Canada (404)
China (128)
Colorado (54)
Connecticut (82)
Delaware (45)
Europe (32954)
Florida (200)
Georgia (40)
Illinois (137)
Indiana (115)
Japan (54)
Maryland (190)
Massachusetts (1289)
Minnesota (48)
New Jersey (538)
New York (424)
North Carolina (343)
Northern California (697)
Ohio (57)
Pennsylvania (323)
South America (295)
Southern California (532)
Texas (137)
Utah (45)
Washington State (190)
219,984 Results for "frontier medicines".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Frontier Medicines Appoints Gerardo Ubaghs as Chief Financial Officer and Announces $20 Million Series C Extension
Frontier Medicines Corporation announced the appointment of Gerardo Ubaghs as Chief Financial Officer and the additional close of $20 million extension to its Series C, bringing the total amount raised to $100 million, with the financing slated to accelerate multiple pipeline programs.
June 25, 2024
·
3 min read
Biotech Bay
Frontier Medicines to Participate in Upcoming Investor Conferences - February 27, 2024
Frontier Medicines Corporation announced that Chris Varma, Ph.D., Frontier’s co-founder, chairman, and CEO, will participate in the upcoming Evercore ISI Emerging Private Biotech Conference, TD Cowen Annual Health Care Conference, and Leerink Partners Global Biopharma Conference.
February 27, 2024
·
1 min read
Biotech Bay
Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline
Frontier Medicines Corporation announced the close of an oversubscribed $80 million Series C financing.
February 22, 2024
·
4 min read
Biotech Bay
Frontier Medicines to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Frontier Medicines Corporation announced that Chris Varma, Ph.D., Frontier’s co-founder, chairman, and CEO, will present a company overview at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 11:30 a.m. PT.
January 3, 2024
·
1 min read
Drug Development
Frontier Medicines to Present Preclinical Data at the American Association for Cancer Research Annual Meeting 2024
Frontier Medicines Corporation announced new preclinical data for FMC-376, a first-in-class direct dual inhibitor of ON+OFF KRASG12C currently being explored in a Phase 1/2 trial, will be shared at the upcoming American Association for Cancer Research Annual Meeting 2024.
March 6, 2024
·
2 min read
Biotech Bay
Frontier Medicines Presents New Data for First-In-Class Dual ON+OFF KRAS G12C Inhibitor FMC-376 at the AACR Annual Meeting
Frontier Medicines Corporation presented new preclinical data on its KRASG12C inhibitor, FMC-376, at the American Association for Cancer Research Annual Meeting 2024 in San Diego, California.
April 9, 2024
·
4 min read
Press Releases
Avirmax Inc. to Present at the ARVO Frontiers in Ocular Gene Therapy Research Conference
November 12, 2024
·
2 min read
Oncoinvent to Present at Cantor Fitzgerald Frontiers in Radiopharma Virtual Summit
Oncoinvent AS today announced that members of management will participate in a virtual fireside chat at the Cantor Fitzgerald Frontiers in Radiopharma Virtual Summit on Monday, May 20, 2024 at 9:00 a.m. ET.
May 15, 2024
·
2 min read
Press Releases
Indaptus Therapeutics’ Pioneering Research on Novel Immunotherapy Approach Published in Peer-Reviewed Frontiers in Immunology
November 11, 2024
·
10 min read
Lone Star Bio
Coya Therapeutics Announces Publication of ALS Study in Peer-Reviewed Journal Frontiers in Neurology
Coya Therapeutics, Inc. announces the publication of a peer-reviewed manuscript titled, “A Phase 1 Proof-of-Concept Study Evaluating Safety, Tolerability, and Biological Marker Responses with Combination Therapy of CTLA4-Ig and Interleukin-2 in Amyotrophic Lateral Sclerosis,” in the medical journal Frontiers in Neurology.
June 11, 2024
·
13 min read
1 of 21,999
Next
